Business Wire

CA-XPRIZE

22.12.2020 22:02:12 CET | Business Wire | Press release

Share
XPRIZE Announces Winners of Million Dollar Next-Gen Mask Challenge to Reveal the Next Generation of Face Masks Following a Virtual Pitch Slam

XPRIZE , a nonprofit organization that uses global competitions to crowdsource solutions to some of the world’s biggest challenges, is pleased to announce that, following last week’s pitch slam, Luminosity Lab from the United States has been named the grand prize winner of the organization’s Next-Gen Mask Challenge . Selected by the competition’s panel of judges, which included a diverse set of industry professionals and executives, Luminosity Lab was chosen from the other finalists for their mask’s design, x-factor of style, early assessments of accessibility and functionality. The winning team is student-led and developed the FloeMask, which uses a bifurcated filtration chamber to achieve filtration and breathability for use everyday and during exercise, diverting heat from the wearer’s face.

Luminosity Lab is from Arizona State University in Tempe, Arizona and includes Nikhil Dave (age 20), Tarun Suresh (age 22), Katie Sue Pascavis (age 19), John Patterson (age 22) and Jerina Winter Gabriel (age 20). The team of five felt compelled to spring into action after witnessing the devastating impact the COVID-19 pandemic had on their Arizona community. Within the first few months of the crisis, the students behind Luminosity Lab helped develop the PPE Response Network , which was responsible for crowdsourcing 3D printers across Arizona to create and distribute over 15,000 units of PPE to clinics facing shortages, and designed two patent-pending technologies capable of sterilizing disposable N95 masks for reuse. Their participation in the XPRIZE Next-Gen Mask Challenge was driven by their desire to design a better way to protect those that choose to wear a mask and help communities around the world. The winning team will receive a total prize purse of $500,000, exiting the competition with the network and knowledge needed to further refine their prototype, and ensure it meets filtration requirements, should they decide to bring their design to market in the future.

In addition, two teams, Polair from John Hopkins University in Maryland and Naija Force from Abuja, Nigeria, have been named runners up in the competition and will split $500,000 as the two category winners. Team Polair, composed of 25 engineering undergraduates, was chosen as the Future Forward Award winner and won $250,000 for their prototype’s modular design which allows users to swap out mask bodies and choose a filter based on their environment. Naija Force won $250,000 as the winner of the ‘Mass’k Appeal Award for the transparent face mask they designed, which features straps that can be worn over the ear or on-head. These teams will now begin the process of refining their mask to ensure they meet key filtration metrics.

Launched this July amid the COVID-19 pandemic, the XPRIZE Next-Gen Mask Challenge, sponsored by Salesforce CEO Marc Benioff and CNBC host Jim Cramer, asked young inventors between the ages of 15-24 to develop the next generation of protective face masks. Throughout the competition, teams had the opportunity to interact with the challenge’s seven industry partners, who lent their expertise to contestants, including: 3M , Autodesk Inc. , Bryan Cave Leighton Paisner LLP, Honeywell , Lydall, National Association of Manufacturers (NAM) and Under Armour . The competition, which received record entries with 992 teams from 76 countries expressing interest within two months, encouraged teams to design a face mask that overcame at least five of the top ten barriers to mask-wearing, as defined by an XPRIZE-conducted survey. Those common barriers to use included: fogging of glasses, getting too hot, being uncomfortable, causing breathing difficulties, making conversations challenging, prohibiting exercise while wearing, causing pain or not fitting properly, blocking facial expressions, preventing eating or drinking, not being eco-friendly, looking ugly or boring, and difficulty acquiring.

Winning teams were chosen, and final judging was conducted by a panel of experts that included:

  • Ashish Diwanji, president of Lydall Performance Materials
  • Brian Hovey, vice president, marketing and commercial excellence at Honeywell
  • Denise Rutherford, senior vice president - corporate affairs at 3M
  • Dr. Erik Viirre, professor at University of California San Diego’s Department of Neurosciences and director at the Arthur C. Clarke Center for Human Imagination
  • Garret Gerson, CEO of Calamigos Ranch
  • Heather Hughes, group vice president/general merchandise manager seasonal, general merchandise and photo at Walgreens
  • June Ambrose, award-winning creative director, author, costume designer and celebrity stylist
  • Dr. Kimberly Prather, professor and distinguished chair in atmospheric chemistry at University of California San Diego
  • Summer Chamblin, Gen-Z entrepreneur, content creator and daughter of June Ambrose
  • Suzanne DiBianca, chief impact officer at Salesforce

Additionally, XPRIZE is pleased to share that team Novus has won the $10,000 People’s Vote Bonus Award which was open to all Next-Gen Mask Challenge top twenty-five teams. The social media-based competition asked teams to defend their design and share their best elevator pitch with their friends, families and followers on social media. Team Novus, based in India, received the most engagement across their social media channels with over 3,000 reactions and interactions on the posts that featured their elevator pitch explaining their design.

"We are absolutely thrilled to be the winners of the Next-Gen Mask Challenge, and are extremely grateful to XPRIZE and all of the incredible sponsors and partners of this event,” said Nikhil Dave of Luminosity Lab. “Since COVID-19 first hit our community in March, we have sought out every way in which we can help - whether it be through crowdsourcing 3D-printed PPE, developing sterilization systems for N95 masks, or even designing our own next-generation mask. We can’t wait to continue pushing to support our global community in every way possible and are absolutely thrilled to have the opportunity to continue this work with the support and encouragement of XPRIZE.”

“We congratulate the winners of the competition,” said Jim Cramer, the host of Mad Money on CNBC. “When we started this journey, we wanted to create awareness among young people for the need to wear masks. We are gratified to have so many entries from around the world. Now the hard work begins as our young champions set out to develop these masks into ones that will be demonstrated to be effective and can be worn around the globe to try to stop the spread of COVID-19.”

“Wearing a mask is one of the most important steps we can take in defeating this pandemic,” said Marc Benioff. “The XPRIZE Next-Gen Mask Challenge has unleashed the talent of some of the most incredible young innovators who are eager to help create a healthier future for us all.”

Teams will receive their winnings within sixty days and will work independently as they choose to finalize their prototypes utilizing the insight provided throughout the competition and final feedback from the judges. Those interested in following along can do so at xprize.org/mask , theluminositylab.com , teampolair.com and teamnaijaforce.com.ng . For additional information on XPRIZE, please visit www.xprize.org .

ABOUT XPRIZE

XPRIZE, a 501(c)(3) nonprofit, is the global leader in designing and implementing innovative competition models to solve the world’s grandest challenges. Active competitions include the $20 Million NRG COSIA Carbon XPRIZE, the $10 Million Rainforest XPRIZE, the $10 Million ANA Avatar XPRIZE, the $5 Million IBM Watson AI XPRIZE and the $5 Million XPRIZE Rapid Reskilling. For more information, visit xprize.org .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release

Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P

Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release

Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release

Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said

SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release

In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin

Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release

Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye